Schedule 13G ownership disclosure
Xencor Inc
Common Stock, par value $0.01 per share · CUSIP: 98401F105
Event date: 2025-10-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BIOTECHNOLOGY VALUE FUND L P
Shares: 2,467,127.00 · Class: 3.5%
- BVF I GP LLC
Shares: 2,467,127.00 · Class: 3.5%
- BIOTECHNOLOGY VALUE FUND II LP
Shares: 1,793,209.00 · Class: 2.5%
- BVF II GP LLC
Shares: 1,793,209.00 · Class: 2.5%
- Biotechnology Value Trading Fund OS LP
Shares: 286,542.00 · Class: 0.4%
- BVF Partners OS Ltd.
Shares: 286,542.00 · Class: 0.4%
- BVF GP HOLDINGS LLC
Shares: 4,260,336.00 · Class: 6.0%
- BVF PARTNERS L P/IL
Shares: 4,619,341.00 · Class: 6.5%
- BVF INC/IL
Shares: 4,619,341.00 · Class: 6.5%
- LAMPERT MARK N
Shares: 4,619,341.00 · Class: 6.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-002762
- Form type
- SCHEDULE 13G
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Oct 17, 2025
- Reporting period
- Oct 09, 2025
- Description
- Schedule 13G beneficial ownership